Hyejung Won is an Associate Professor in the Department of Genetics and Neuroscience Center at the University of North Carolina at Chapel Hill. She received her B.S. and Ph.D. in Biology from Korea Advanced Institute of Science and Technology (KAIST), where she conducted research revealing the underlying mechanism of neurodevelopmental conditions using genetically modified mice under the supervision of Dr. Eunjoon Kim. She then joined Dr. Dan Geschwind’s group at UCLA, where she established Hi-C, a genome-wide chromosome conformation capture technology, and generated chromatin interaction profiles from the developing and adult human brain. Her lab leverages the genomics approach to bridge the gap between genetic risk factors and neurobiological mechanisms by mapping genetic variants of unknown function to the genes that they regulate, and identifying how dysfunctional gene regulation contributes to disease pathogenesis. Hyejung is the recipient of the NIH Director’s New Innovator Award, McKnight Neurobiology of Brain Disorders Award, Jefferson Pilot Award, HHMI Gilliam Fellowship, NIH Pathway to Independence Award, and a NARSAD Young Investigator Award. She also serves as the Principal Investigator (PI) for several large-scale collaborative efforts: the PsychENCODE Consortium to create the comprehensive molecular resource of the human brain; the IGVF Consortium to characterize the impact of GWAS variants on genome function; the SCORCH Consortium to generate a cell type-specific molecular atlas relevant to opioid use disorder; and the PGC Functional Genomics Working Group, where she co-leads the Functional Validation Focus Group.